Letter: impact of HBV genotypes and PC/BCP mutations on serum HBsAg levels in Chinese HBeAg negative patients-Authors' reply

L Kuhnhenn^{1

2}, B Jiang², A Kubesch¹, S Zeuzem¹, C Sarrazin^{1

3}, E Hildt^{2

4}, K-H Peffer^{1

2}

Affiliations

¹ Department of Gastroenterology and Hepatology, University Hospital Frankfurt, Frankfurt, Germany.
² Division of Virology, Paul Ehrlich Institute, Langen, Germany.
³ Department of Gastroenterology, St. Josefs Hospital, Wiesbaden, Germany.
⁴ German Center for Infection Research (DZIF), Langen, Germany.

Comment

L Kuhnhenn et al. Aliment Pharmacol Ther. 2018 Jul.

. 2018 Jul;48(2):238-239.

doi: 10.1111/apt.14836.

L Kuhnhenn^{1

2}, B Jiang², A Kubesch¹, S Zeuzem¹, C Sarrazin^{1

3}, E Hildt^{2

4}, K-H Peffer^{1

2}

¹ Department of Gastroenterology and Hepatology, University Hospital Frankfurt, Frankfurt, Germany.
² Division of Virology, Paul Ehrlich Institute, Langen, Germany.
³ Department of Gastroenterology, St. Josefs Hospital, Wiesbaden, Germany.
⁴ German Center for Infection Research (DZIF), Langen, Germany.

No abstract available

Comment on

Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection.
Kuhnhenn L, Jiang B, Kubesch A, Vermehren J, Knop V, Susser S, Dietz J, Carra G, Finkelmeier F, Grammatikos G, Zeuzem S, Sarrazin C, Hildt E, Peiffer KH. Kuhnhenn L, et al. Aliment Pharmacol Ther. 2018 Jun;47(11):1523-1535. doi: 10.1111/apt.14636. Epub 2018 Apr 10. Aliment Pharmacol Ther. 2018. PMID: 29637585 Clinical Trial.
Letter: impact of HBV genotypes and PC/BCP mutations on serum HBsAg levels in Chinese HBeAg-negative patients.
Chen EQ, Wang ML, Wu DB, Liao J, Tang H. Chen EQ, et al. Aliment Pharmacol Ther. 2018 Jul;48(2):236-237. doi: 10.1111/apt.14815. Aliment Pharmacol Ther. 2018. PMID: 29939408 No abstract available.